echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Innovative anti-tumor drug YS-ON-001 starts phase I clinical trial in Tianjin

    Innovative anti-tumor drug YS-ON-001 starts phase I clinical trial in Tianjin

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 9, 2021, the Phase I clinical trial of YS-ON-001, an innovative drug independently developed by EsenBio, was held in Tianjin Cancer Hospital


    It is reported that YS-ON-001 is a biological preparation developed based on PIKA adjuvant


    Through studying its mechanism of action, the researchers found that the drug can significantly enhance the activation level of macrophages and dendritic cells, increase the expression of cytokines, enhance the activation level of NK cells and NKT cells in the tumor microenvironment, and down-regulate the regulation.


    Pharmacodynamic research results show that YS-ON-001 has a high tumor growth inhibition rate in animal models of breast cancer, lung cancer, liver cancer, colorectal cancer and prostate cancer


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.